Seeking Alpha

Bayer bullish on sales

  • Bayer (BAYRY) believes that it will increase sales by at least 8% per year until 2016 due to robust sales of new products. It forecasts peak sales of $10.4B for five new drugs.
  • The products are Xarelto, Eylea, Stivarga, Xofigo and Adempas.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: